Headline

Global Healthcare Executive | Strategy, Innovation, Marketing

About

With over 20 years of progressive experience in the healthcare industry, I am general manager / senior director at Honeywell, leading the breakthrough initiatives in healthcare division. I have a strong background in corporate and business unit strategy, upstream and downstream marketing, product launch, field sales, finance, integration, and R&D in medical technology, biopharma, and consulting. My mission is to identify, evaluate, and execute innovative and impactful solutions that address the unmet needs of patients, providers, and payers. I have successfully launched five products in the interventional pain management market, delivered key elements of the strategic plan, and led the R&D's external opportunities and partnerships efforts. I have a proven track record of collaborating with cross-functional teams, developing product roadmaps, conducting technology assessments, and establishing probability of success. I hold an MBA from Wharton and BS/MSE degrees in Biomedical Engineering from Johns Hopkins.

Location

Dallas-Fort Worth Metroplex

AI stack

antigravity

codex

claudecode

Work experience

Co-Founder and Principal at Netra Health, LLC, May 2022 - Present · 4 yrs 4 mos, Dallas-Fort Worth Metroplex

Senior Director, Breakthrough Initiatives in Healthcare at Honeywell, Jun 2022 - Nov 2024 · 2 yrs 6 mos, Richardson, Texas, United States

Director, Global and Upstream Marketing at Abbott, Feb 2019 - Jun 2022 · 3 yrs 5 mos, Dallas/Fort Worth Area, Strategic Marketing, Product Management, Business Development, and Leadership • Lead eight-person team focused on global and upstream marketing, business development for $800MM division • Launched five products including: radiofrequency generator (Ionic RF); software allowing for greater use of MRI, bring your own device patient controllers; first to world remote programming system; and longitudinal patient app (MyPath) • Delivered key elements of strategic plan, evaluation of a changing interventional pain landscape (e.g. shift to minimally invasive surgery), and prioritization of innovation budget across R&D, clinical, and digital to shape next 5-year cadence

Global Head, External Opportunities, Deals and Partnerships, R&D at Alcon, May 2017 - Jan 2019 · 1 yr 9 mos, Dallas/Fort Worth Area, Business Development, Technology Assessment, Development Planning • Led R&D’s external opportunities and partnerships efforts through evaluating technology assessments, developing product roadmaps, outlining multi-year development/clinical/regulatory plans, establishing probability of success, integration plans • Directed and ensured alignment of various functional leaders (e.g. sr. leadership, technical development, clinical, regulatory affairs, legal/intellectual property, transactions, medical affairs, finance) through biweekly external technology reviews • Publicly disclosed transactions include acquisition of Tear Film Innovations, PowerVision, TrueVision and partnership with MOVU; numerous other licensing and equity investments not disclosed • Led R&D wide effort to look at all spending categories and brainstorm and assess opportunities to outsource activities

Project Head, Intraocular Cataract Lenses at Alcon, Jul 2015 - May 2017 · 1 yr 11 mos, Dallas/Fort Worth Area, Product design and development, Regulatory planning, and Product launch • Returned and converted the $100MM+ Japan intraocular lens (IOL) portfolio effected by recalls through manufacturing process improvements, that have led to one of Alcon’s highest clarity lens (“A” code) • Achieved CE mark and launched innovative presbyopia and astigmatism correcting IOL, PanOptix Toric, by building development plan, performing equivalence and registration testing, navigating the changing EU MedDev regulations, and working with global and area marketing and supply chain • Awarded Global Alcon Excellence Award for Customer Focus

Head, Project Management Office Alcon-WaveTec at Alcon, Sep 2014 - Jul 2015 · 11 mos, Orange County, California Area, Post-merger integration, Product launch, Manufacturing and Distribution scaling • Led all aspects of integration of WaveTec into Alcon including coordination between 13 functional leads and their teams • Executed on plan to exceed deal model, driven by higher sales, higher pricing, and inclusion of subscription fees • Launched new product, VerifEye+ including modular distribution and established intraoperative aberrometry globally • Increased production capabilities by 3x in 2015 and established scaling plan for up 6x in 2016 • Hired 35+ FTEs and integrating processes across quality, MTO, R&D, and commercial to continue business operations

Co-Founder and Business Advisor at Netra Health, LLC, Feb 2014 - May 2022 · 8 yrs 4 mos

Director, Strategy and Analytics at Reata Pharmaceuticals, Sep 2012 - Dec 2012 · 4 mos, Dallas/Fort Worth Area, • Led cross-functional strategic planning process for pre-commercial biopharmaceutical company • Advised functional areas through projects ranging from clinical operations capacity planning to process design • Independent monitoring committee recommended closure of Phase III BEACON trial due to patient safety

Education

MBA, Strategy, Healthcare, The Wharton School

MSE/BS, Biomedical Engineering, The Johns Hopkins University